Photo of Gizeh Perez-Tenorio

Gizeh Perez-Tenorio

Principal Research Engineer, Docent



Annelie Johansson, Huma Dar, Laura J. van t Veer, Nicholas P. Tobin, Gizeh Perez-Tenorio, Anna Nordenskjöld, Ulla Johansson, Johan Hartman, Lambert Skoog, Christina Yau, Christopher C. Benz, Laura J. Esserman, Olle Stål, Bo Nordenskjöld, Tommy Fornander, Linda S. Lindstrom (2022) Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial Journal of Clinical Oncology, Vol. 40, p. 4071-4082 Continue to DOI
Jenny Pousette, Annelie Johansson, Carolin Jönsson, Tommy Fornander, Linda S. Lindström, Hans Olsson, Gizeh Perez-Tenorio (2022) Prognostic and Predictive Significance of Stromal Tumor-Infiltrating Lymphocytes (sTILs) in ER-Positive/HER2-Negative Postmenopausal Breast Cancer Patients Cancers, Vol. 14, Article 4844 Continue to DOI
Annelie Johansson, Nancy Y. Yu, Adina Iftimi, Nicholas P. Tobin, Laura Van 'T Veer, Bo Nordenskjöld, Christopher C. Benz, Tommy Fornander, Gizeh Pérez-Tenorio, Olle Stål, Laura J. Esserman, Christina Yau, Linda S. Lindström (2022) Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signature International Journal of Cancer, Vol. 150, p. 2072-2082 Continue to DOI


Huma Dar, Annelie Johansson, Anna Nordenskjöld, Adina Iftimi, Christina Yau, Gizeh Perez-Tenorio, Christopher Benz, Bo Nordenskjöld, Olle Stål, Laura J. Esserman, Tommy Fornander, Linda S. Lindström (2021) Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial JAMA Network Open, Vol. 4, Article e2114904 Continue to DOI
Josefine Sandström, Alien Balian, Rebecca Lockowandt, Tommy Fornander, Bo Nordenskjöld, Linda Lindstrom, Gizeh Perez Tenorio, Olle Stål (2021) IP6K2 predicts favorable clinical outcome of primary breast cancer Molecular and clinical oncology, Vol. 14, Article 94 Continue to DOI